ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 142 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,345,000 | -56.3% | 25,164 | -7.7% | 0.21% | -47.9% |
| Q4 2015 | $3,079,000 | +212.0% | 27,253 | +59.7% | 0.40% | +253.5% |
| Q1 2015 | $987,000 | +0.2% | 17,070 | -44.1% | 0.11% | -16.8% |
| Q4 2014 | $985,000 | -19.3% | 30,558 | -38.7% | 0.14% | -44.8% |
| Q3 2014 | $1,220,000 | +38.0% | 49,865 | 0.0% | 0.25% | +47.6% |
| Q2 2014 | $884,000 | -70.0% | 49,865 | -66.2% | 0.17% | -68.4% |
| Q1 2014 | $2,950,000 | -4.6% | 147,445 | -20.0% | 0.53% | -4.0% |
| Q4 2013 | $3,093,000 | +40.7% | 184,321 | -10.9% | 0.55% | +26.5% |
| Q3 2013 | $2,198,000 | – | 206,933 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |